One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/S0167-8140(24)00719-9
Volume 198, September 2024, 110449
Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified, phase II trial
Time is NTCP: Should we maximize patient throughput or perform online adaptation on proton therapy systems?
External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer
FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls
Robustness of intensity modulated proton treatment of esophageal cancer for anatomical changes and breathing motion
Radiation enhancement using focussed ultrasound-stimulated microbubbles for head and neck cancer: A phase 1 clinical trial
Efficacy and safety of boron neutron capture therapy for Hypopharyngeal/Laryngeal cancer patients with previous head and neck irradiation
FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissection
Predictive value of primary tumor volume change during concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer
Quantitative analysis of interstitial lung abnormalities on computed tomography to predict symptomatic radiation pneumonitis after lung stereotactic body radiotherapy
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19Â Gy or two fractions of 13.5Â Gy: A 9-year update
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field
Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy
Long-term outcomes following proton therapy for non-metastatic central nervous system germinoma in children and adolescents
Challenges and opportunities in the development and clinical implementation of artificial intelligence based synthetic computed tomography for magnetic resonance only radiotherapy
Reducing the lateral dose penumbra in IMPT by incorporating transmission pencil beams
Lymphocyte radiosensitivity: An extension to the linear-quadratic model?
Artificial intelligence-assisted quantitative CT analysis of airway changes following SABR for central lung tumors
HaN-Seg: The head and neck organ-at-risk CT and MR segmentation challenge
Multicenter privacy-preserving model training for deep learning brain metastases autosegmentation
Validation and reproducibility of in vivo dosimetry for pencil beam scanned FLASH proton treatment in mice
Radiation necrosis and survival issues commentary in the articles by Desideri et al.
Letter to the editor regarding “Risk factors associated with the development of osteoradionecrosis (ORN) in head and neck cancer patients in Ireland: A 10-year retrospective review�
Response to letter to the editor by Somay et al., re: “Risk factors associated with the development of osteoradionecrosis (ORN) in head and neck cancer patients in Ireland: A 10-year retrospective review�
Corrigendum to “A systematic analysis of the particle irradiation data ensemble in the key of the microdosimetric kinetic model: Should clonogenic data be used for clinical relative biological effectiveness?� [Radiother. Oncol. 185 (2023) 109730]
